Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jon Trærup Andersen

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
JAMA Pediatrics|January 19, 2021
Pros and Cons in Using Population-Based Registers for Assessing the Fetal Safety of Drugs-ReplyNiklas Worm Andersson, Jon Trærup Andersen
JAMA Dermatology|January 9, 2020
Association Between Fetal Safety Outcomes and Exposure to Local Podophyllotoxin During PregnancyNiklas Worm Andersson, Jon Trærup Andersen
JAMA Internal Medicine|December 7, 2020
Variation in Biosimilar Uptake in EuropeJon Trærup Andersen, Thomas Bo Jensen
British Journal of Clinical Pharmacology|June 1, 2026
Methyldopa and the risk of peripartum depression-A nationwide registry-based studyJoachim Hjalde Halmsted Olsen, Jon Trærup Andersen
JAMA Dermatology|May 5, 2021
Evaluation of Topical Corticosteroid Use in Pregnancy and Risk of Newborns Being Small for Gestational Age and Having Low Birth WeightNiklas Worm Andersson, Lone Skov, Jon Trærup Andersen
Journal of the American Academy of Dermatology|March 21, 2020
Paternal acitretin exposure and the risk of miscarriage and major congenital malformations: A nationwide register-based cohort studyMia Noergaard, Stine Soendersted Clausen, Jon Trærup Andersen
Rheumatology (Oxford, England)|November 24, 2020
Fetal safety of chloroquine and hydroxychloroquine use during pregnancy: a nationwide cohort studyNiklas Worm Andersson, Lone Skov, Jon Trærup Andersen
Journal of the American Academy of Dermatology|January 15, 2021
Exposure to terbinafine in pregnancy and risk of preterm birth, small for gestational age, low birth weight, and stillbirth: A nationwide cohort studyNiklas Worm Andersson, Simon Francis Thomsen, Jon Trærup Andersen
Archives of Disease in Childhood. Fetal and Neonatal Edition|October 7, 2019
Patent ductus arteriosus closure: why same-dose oral ibuprofen is superior to intravenousThomas Bo Jensen, Jens Peter Kampmann, Jon Trærup Andersen
JAMA Dermatology|March 5, 2020
Evaluation of Association Between Oral and Topical Terbinafine Use in Pregnancy and Risk of Major Malformations and Spontaneous AbortionNiklas Worm Andersson, Simon Francis Thomsen, Jon Trærup Andersen
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
JAMA Pediatrics|January 19, 2021
Pros and Cons in Using Population-Based Registers for Assessing the Fetal Safety of Drugs-ReplyNiklas Worm Andersson, Jon Trærup Andersen
JAMA Dermatology|January 9, 2020
Association Between Fetal Safety Outcomes and Exposure to Local Podophyllotoxin During PregnancyNiklas Worm Andersson, Jon Trærup Andersen
JAMA Internal Medicine|December 7, 2020
Variation in Biosimilar Uptake in EuropeJon Trærup Andersen, Thomas Bo Jensen
British Journal of Clinical Pharmacology|June 1, 2026
Methyldopa and the risk of peripartum depression-A nationwide registry-based studyJoachim Hjalde Halmsted Olsen, Jon Trærup Andersen
JAMA Dermatology|May 5, 2021
Evaluation of Topical Corticosteroid Use in Pregnancy and Risk of Newborns Being Small for Gestational Age and Having Low Birth WeightNiklas Worm Andersson, Lone Skov, Jon Trærup Andersen
Journal of the American Academy of Dermatology|March 21, 2020
Paternal acitretin exposure and the risk of miscarriage and major congenital malformations: A nationwide register-based cohort studyMia Noergaard, Stine Soendersted Clausen, Jon Trærup Andersen
Rheumatology (Oxford, England)|November 24, 2020
Fetal safety of chloroquine and hydroxychloroquine use during pregnancy: a nationwide cohort studyNiklas Worm Andersson, Lone Skov, Jon Trærup Andersen
Journal of the American Academy of Dermatology|January 15, 2021
Exposure to terbinafine in pregnancy and risk of preterm birth, small for gestational age, low birth weight, and stillbirth: A nationwide cohort studyNiklas Worm Andersson, Simon Francis Thomsen, Jon Trærup Andersen
Archives of Disease in Childhood. Fetal and Neonatal Edition|October 7, 2019
Patent ductus arteriosus closure: why same-dose oral ibuprofen is superior to intravenousThomas Bo Jensen, Jens Peter Kampmann, Jon Trærup Andersen
JAMA Dermatology|March 5, 2020
Evaluation of Association Between Oral and Topical Terbinafine Use in Pregnancy and Risk of Major Malformations and Spontaneous AbortionNiklas Worm Andersson, Simon Francis Thomsen, Jon Trærup Andersen
Pageof 7